Axsome Therapeutics (AXSM) Cash & Equivalents Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 7.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.37% |
| Dec 31, 2025 | 17.15% |
| Sep 30, 2025 | 12.66% |
| Jun 30, 2025 | 60.42% |
| Mar 31, 2025 | 52.59% |
| Dec 31, 2024 | 53.92% |
| Sep 30, 2024 | 41.88% |
| Jun 30, 2024 | 30.75% |
| Mar 31, 2024 | 26.26% |
| Dec 31, 2023 | 28.06% |
| Sep 30, 2023 | 27.21% |
| Jun 30, 2023 | 31.85% |
| Mar 31, 2023 | 7.70% |
| Dec 31, 2022 | -2.99% |
| Sep 30, 2022 | 73.40% |
| Jun 30, 2022 | 10.94% |
| Mar 31, 2022 | 25.72% |
| Dec 31, 2021 | 83.61% |
| Sep 30, 2021 | 96.00% |
| Jun 30, 2021 | 90.74% |
| Mar 31, 2021 | 83.54% |
| Dec 31, 2020 | 75.49% |
| Sep 30, 2020 | 85.56% |
| Jun 30, 2020 | 71.21% |
| Mar 31, 2020 | 63.65% |
| Dec 31, 2019 | 81.78% |
| Sep 30, 2019 | 8.80% |
| Jun 30, 2019 | 11.52% |
| Mar 31, 2019 | -1.11% |
| Dec 31, 2018 | -33.75% |
| Sep 30, 2018 | 48.79% |
| Jun 30, 2018 | 46.94% |
| Mar 31, 2018 | 150.69% |